$CSCO Cisco Systems is gaining momentum in pre-market trading after reporting a record fiscal 2026 revenue exceeding $63 billion, marking a 12% increase year-over-year. The company’s strong fourth-quarter results featured $17.3 billion in revenue, an 18% jump, alongside a 23% rise in adjusted earnings per share to $1.22. Cisco highlighted growing demand for AI infrastructure, with $4 billion in Q4 orders and a projected $7.5 billion in AI-related revenue for fiscal 2027. Looking ahead, Cisco expects first-quarter revenue between $18 billion and $18.2 billion and anticipates some margin pressure due to a higher hardware mix, signaling cautious optimism for investors.
$INTC Intel shares climbed over 3% following Bank of America’s reaffirmation of a Buy rating despite a recent $20 billion stock offering priced at $95 per share, which will dilute existing shareholders by about 4-5%. The offering supports Intel’s ambitious foundry expansion plans, aiming to capture a significant slice of the global wafer market by 2030. BofA also noted improved pricing in Intel’s server segment, with average selling prices up 43% year-over-year. However, execution risks remain, particularly around manufacturing yields and competition in advanced packaging, keeping investors attentive to Intel’s operational progress.
$LUCD Lucid Diagnostics reported a slight miss in its Q2 non-GAAP EPS at -$0.06 and revenue of $1.47 million, falling short by $0.46 million despite a 26.7% year-over-year revenue increase. The company processed 2,770 EsoGuard tests and held $33.4 million in cash as of June 30, reflecting a modest cash burn since year-end. These results suggest Lucid is still navigating growth challenges amid its Medicare-driven inflection point.
$EU enCore Energy’s stock dropped 8.1% pre-market after announcing a $250 million at-the-market equity program. This controlled offering allows the uranium-focused company to sell shares at prevailing prices to fund potential acquisitions, strategic growth, and general corporate needs. The move indicates enCore’s intent to capitalize on rising uranium spot prices while managing capital flexibility.
$NUWE Nuwellis posted a steep GAAP EPS loss of -$26.24 for Q2, with revenue rising 13.9% year-over-year to $1.97 million. The significant loss underscores ongoing challenges for the healthcare company, though modest revenue growth provides a slight positive signal amid a tough operating environment.
$CADL Candel Therapeutics reported a Q2 GAAP EPS loss of -$0.52, missing estimates by $0.29. The company holds a strong cash position of $201.6 million, expected to fund operations through Q1 2028, including preparations for the potential 2027 commercial launch of its lead therapy aglatimagene. This financial runway offers some stability as Candel advances its late-stage biotech pipeline.
$MGTX MeiraGTx delivered a standout quarter with GAAP EPS of $1.71, beating estimates by $2.15, and revenue soaring to $321.4 million—an extraordinary 8610% increase year-over-year. This dramatic growth reflects successful operational scaling and positions MeiraGTx as a notable player in gene therapy manufacturing and development.
$JD JD.com shares slipped about 4% in pre-market trading despite beating revenue and adjusted earnings estimates for Q2. The Chinese e-commerce giant’s net revenue declined 2.9% year-over-year to $51.1 billion, pressured by cautious consumer spending and stiff competition. While adjusted EBITDA and margins improved, product revenue fell 5.4%, offset partially by a 6.8% rise in service revenue. JD’s CFO highlighted solid profitability gains despite slowing top-line growth, with ongoing share repurchases signaling confidence amid a challenging retail landscape.
$V Visa is among six new investments unveiled by billionaire investor Bill Ackman in his largest portfolio overhaul in years. Alongside Netflix and Mastercard, these additions reflect Ackman’s focus on companies he believes have strong earnings growth potential. This strategic shift comes as Ackman’s funds have faced recent headwinds, and the new stakes are expected to appear in upcoming SEC filings, drawing attention from investors tracking his moves.
$DSP Viant Technology is expanding its footprint in enterprise advertising, securing new contracts with major brands like Molson Coors and WHOOP. The company’s unique data assets—including a household identity graph and TV content recognition tools—are driving increased ad spend. Viant’s AI Outcomes platform now accounts for about 5% of total spending, reflecting growing adoption of data-driven marketing solutions as advertisers shift budgets from traditional TV to streaming platforms. With its largest sales pipeline ever, Viant is positioned for further growth in the evolving programmatic ad market.
U.S. markets are currently closed and will reopen today at 9:30 AM ET, with pre-market trading underway providing early signals on these key stocks.
Did you know?
The stock market has historically rewarded patient investors: the S&P 500 has delivered positive returns in about 75% of calendar years since its inception, highlighting the value of long-term investing over short-term timing.
Disclaimer
This content is for entertainment and discussion purposes only. It is based on publicly available headlines and social media commentary, which can be messy and ever-evolving. We are not financial advisors, and this is not investment advice. The publisher may hold positions in securities mentioned. We aim to keep things accurate—if you catch something off, please let us know.
Powered by - Trading Watch Premium
This data is 100% free and is made possible by our Monthly Supporters.
No Comments